Desflurane
PreclinicalSmall molecule
Desflurane is one of 9 small molecule programs targeting Lumbar Fusion Surgery. It is currently in Preclinical.
2
Indications
5
Total Trials
0
Active Trials
8
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
7 competitors in Cognitive Function
#DrugCompanyPhaseTrials
1Namenda
AbbViePhase 2
Actos
TakedaPhase 2
Provigil
NNuvo Research GmbH
Phase 1
Inderal
WWyeth-Lederle Vaccines
Phase 1
Transderm Scop
BBaxter Healthcare Corporation
Preclinical
Taurine
TThird Military Medical University
Preclinical
Desflurane
ZZhejiang Cancer Hospital
Preclinical
Nattokinase
SSecond Affiliated Hospital, School of Medicine, Zhejiang University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Cognitive Dysfunction1 trial
The Effect of Desflurane on Postopertative Cognitive Dysfunction
Unknown status·—·Phase 4·NCT04541823·100 enrolled
Cognitive Function1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Desflurane. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- ZZhejiang Cancer Hospital